Carregant...
The immunology of type 1 diabetes
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunotherapy that targets T cells as a means to dela...
Guardat en:
| Publicat a: | Nat Rev Immunol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2024
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7616056/ https://ncbi.nlm.nih.gov/pubmed/38308004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-023-00985-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|